News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
744,140 Results
Type
Article (43521)
Company Profile (282)
Press Release (700322)
Multimedia
Podcasts (98)
Webinars (24)
Section
Business (208106)
Career Advice (2075)
Deals (36002)
Drug Delivery (135)
Drug Development (82111)
Employer Resources (176)
FDA (16713)
Job Trends (15199)
News (351449)
Policy (33091)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2718)
Academic (1)
Accelerated approval (51)
Adcomms (28)
Allergies (172)
Alliances (50960)
ALS (214)
Alzheimer's disease (1824)
Antibody-drug conjugate (ADC) (471)
Approvals (17118)
Artificial intelligence (718)
Autoimmune disease (307)
Automation (58)
Bankruptcy (363)
Best Places to Work (11808)
BIOSECURE Act (20)
Biosimilars (228)
Biotechnology (182)
Bladder cancer (199)
Brain cancer (73)
Breast cancer (774)
Cancer (5987)
Cardiovascular disease (481)
Career advice (1766)
Career pathing (43)
CAR-T (339)
CDC (60)
Celiac Disease (3)
Cell therapy (931)
Cervical cancer (49)
Clinical research (71285)
Collaboration (2156)
Company closure (5)
Compensation (1424)
Complete response letters (80)
COVID-19 (2783)
CRISPR (111)
C-suite (1168)
Cystic fibrosis (152)
Data (8112)
Decentralized trials (3)
Denatured (33)
Depression (166)
Dermatology (89)
Diabetes (592)
Diagnostics (7166)
Digital health (58)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (338)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (289)
Earnings (92698)
Editorial (67)
Employer branding (21)
Employer resources (153)
Events (121469)
Executive appointments (1111)
FDA (20519)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1774)
Gene editing (241)
Generative AI (59)
Gene therapy (740)
GLP-1 (1068)
Government (4796)
Grass and pollen (6)
Guidances (409)
Healthcare (19369)
HIV (83)
Huntington's disease (57)
IgA nephropathy (100)
Immunology and inflammation (292)
Immuno-oncology (94)
Indications (196)
Infectious disease (3134)
Inflammatory bowel disease (218)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (296)
Interviews (325)
IPO (16776)
IRA (50)
Job creations (3693)
Job search strategy (1464)
JPM (58)
Kidney cancer (19)
Labor market (103)
Layoffs (570)
Leadership (41)
Legal (7995)
Liver cancer (101)
Longevity (34)
Lung cancer (783)
Lymphoma (434)
Machine learning (61)
Management (60)
Manufacturing (1088)
MASH (191)
Medical device (14185)
Medtech (14316)
Mergers & acquisitions (20508)
Metabolic disorders (1522)
mRNA (214)
Multiple sclerosis (193)
NASH (17)
Neurodegenerative disease (430)
Neuropsychiatric disorders (107)
Neuroscience (3374)
Neurotech (1)
NextGen: Class of 2026 (6676)
Non-profit (4645)
Now hiring (78)
Obesity (711)
Opinion (296)
Ovarian cancer (227)
Pain (259)
Pancreatic cancer (314)
Parkinson's disease (375)
Partnered (33)
Patents (608)
Patient recruitment (685)
Peanut (63)
People (60758)
Pharmaceutical (60)
Pharmacy benefit managers (32)
Phase 1 (22273)
Phase 2 (31406)
Phase 3 (23328)
Pipeline (9031)
Policy (323)
Postmarket research (2583)
Preclinical (9590)
Press Release (68)
Prostate cancer (314)
Psychedelics (54)
Radiopharmaceuticals (338)
Rare diseases (1097)
Real estate (6097)
Recruiting (70)
Regulatory (25771)
Reports (58)
Research institute (2524)
Resumes & cover letters (357)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (179)
Series A (297)
Series B (218)
Service/supplier (11)
Sickle cell disease (114)
Special edition (24)
Spinal muscular atrophy (169)
Sponsored (49)
Startups (3717)
State (2)
Stomach cancer (18)
Supply chain (129)
Tariffs (88)
The Weekly (63)
Vaccines (1116)
Venture capital (111)
Weight loss (458)
Women's health (130)
Worklife (21)
Date
Today (123)
Last 7 days (538)
Last 30 days (3441)
Last 365 days (30657)
2026 (13446)
2025 (30638)
2024 (35616)
2023 (40571)
2022 (51675)
2021 (56274)
2020 (54838)
2019 (47546)
2018 (35737)
2017 (32699)
2016 (32116)
2015 (38224)
2014 (31855)
2013 (27020)
2012 (29209)
2011 (29902)
2010 (27893)
Location
Africa (767)
Alabama (94)
Alaska (7)
Arizona (352)
Arkansas (14)
Asia (40801)
Australia (6681)
California (13575)
Canada (3821)
China (1397)
Colorado (571)
Connecticut (584)
Delaware (421)
Europe (89186)
Florida (2022)
Georgia (435)
Hawaii (3)
Idaho (63)
Illinois (1071)
India (95)
Indiana (615)
Iowa (24)
Japan (553)
Kansas (135)
Kentucky (51)
Louisiana (45)
Maine (76)
Maryland (1623)
Massachusetts (9696)
Michigan (372)
Minnesota (739)
Mississippi (6)
Missouri (146)
Montana (34)
Nebraska (29)
Nevada (149)
New Hampshire (85)
New Jersey (3554)
New Mexico (30)
New York (3537)
North Carolina (1719)
North Dakota (10)
Northern California (6811)
Ohio (410)
Oklahoma (24)
Oregon (42)
Pennsylvania (2710)
Puerto Rico (29)
Rhode Island (50)
South America (1148)
South Carolina (87)
South Dakota (2)
Southern California (5356)
Tennessee (216)
Texas (2182)
United States (47838)
Utah (406)
Vermont (1)
Virginia (330)
Washington D.C. (81)
Washington State (1078)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
744,140 Results for "integral molecular inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
Degron Therapeutics will have stiff competition in immunology, as Novartis inked a $5.7 billion agreement with Monte Rosa Therapeutics last year to develop molecular glues for undisclosed immune-mediated conditions.
May 14, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery
May 20, 2026
·
5 min read
Press Releases
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
April 16, 2026
·
5 min read
Artificial intelligence
Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling
A trifecta of newly inked tech partnerships—from Eli Lilly, Bristol Myers Squibb and Incyte—exemplify the increasingly central role that AI is playing in drug development.
May 21, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing
May 8, 2026
·
3 min read
Press Releases
Cubit Diagnostics Closes SAFE Financing to Advance Molecular Assay Development and Expand Immunoassay Menu
May 8, 2026
·
2 min read
Press Releases
Degron Therapeutics Closes $40 Million Series A Extension to Support Molecular Glue Degrader Clinical Development
May 14, 2026
·
5 min read
Press Releases
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
March 10, 2026
·
7 min read
Press Releases
Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) Platform
April 17, 2026
·
5 min read
Press Releases
Mimulus and GenScript Partner to Scale the World’s First Zero-Watt Molecular Archive Infrastructure for the AI Era
April 9, 2026
·
5 min read
1 of 74,414
Next
